The Enzymology of Skeletal Muscle Disorders

References

• Rosalki S. B. Enzymes in diseases of skeletal muscle. The Principles and Practice of Diagnostic Enzymology, J. H. Wilkinson. Year Book Medical Publishing, Chicago 1976; 261
   Google Scholar
• Robbins S. L. Pathologic Basis of Disease. W. B. Saunders, Philadelphia 1974; 1420
   Google Scholar
• Tyler F. H. Metabolic Basis of Inherited Diseases. 3rd ed., J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson. McGraw-Hill, New York 1972; 1204
   Google Scholar
• Gardner-Medwin D. Clinical features and classification of the muscular dystrophies. Br. Med. Bull. 1980; 36: 109
   PubMed Web of Science ®Google Scholar
• Emery A. E. H. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br. Med. Bull. 1980; 36: 117
   Google Scholar
• Roses A. D., Roses M. J., Nicholson G. A., et al. Lactate dehydrogenase isoenzyme 5 in detecting carriers of Duchenne muscular dystrophy. Neurology 1977; 27: 414
   Google Scholar
• Burt D., Emery A. F. H. Serum LDH-5 in carriers of Duchenne muscular dystrophy. Neurology 1979; 29: 239
   Google Scholar
• Somer H., Willner J., deCresce R. P., et al. Duchenne carriers: lactate dehydrogenase isoenzyme 5 in serum and muscle. Neurology 1980; 30: 206
   Google Scholar
• Lindenbaum R. H., Clarke G., Patel C., et al. Muscular dystrophy in an X; 1 translocation female suggests that Duchenne locus is on X chromosome short arm. J. Med. Genet. 1979; 16: 389
   PubMedGoogle Scholar
• Tzvetanova E. Serum creatine kinase isoenzymes in progressive muscular dystrophy. Enzyme 1978; 23: 238
   Google Scholar
• Takahashi K., Shutta K., Matsuo B., et al. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy. Clin. Chem. Acta 1977; 75: 422
   Google Scholar
• Lott J. A., Stang J. M. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin. Chem. 1980; 26: 1241
   PubMed Web of Science ®Google Scholar
• Silverman L. M., Mendell J. R., Sahenk Z., et al. Significance of creatine kinase isoenzymes in Duchenne dystrophy. Neurology 1976; 26: 561
   PubMed Web of Science ®Google Scholar
• Perloff J. Cardiomyopathy associated with heredofamilial neuropathic diseases. Mod. Concepts Cardiovasc. Dis. 1971; 40: 23
   Google Scholar
• Somer H., Dubowitz V., Donner M. Creatine kinase isoenzymes in neuromuscular diseases. J. Neurol. Sci. 1976; 29: 129
   PubMedGoogle Scholar
• Jockers-Wretou E., Grabert K., Mueller E., et al. Serum creatine kinase isoenzyme pattern in nervous system atrophies and neuromuscular disorders. Clin. Chim. Acta. 1976; 73: 183
   PubMed Web of Science ®Google Scholar
• Goedde H. W., Benkmann H. G., Das P. K., et al. Activity of creatine kinase isoenzyme MB in serum and red cell acetylcholinesterase variants in patients with Duchenne muscular dystrophy. Klin. Wschr. 1977; 55: 215
   Google Scholar
• Goedde H. W., Christ I., Benkmann H. G., et al. Creatine kinase isoenzyme patterns in Duchenne muscular dystrophy. Clin. Genet. 1978; 14: 257
   Google Scholar
• Diskin C. J. Creatine phosphokinase MB band in oculopharyngeal muscular dystrophy. New Engl. J. Med. 1979; 301: 270
   Google Scholar
• Calandi C., Guidotti T., Tozzi P., et al. Valutazione della Piruvatochinasi Sierica nei Pazienti affetti da Distrofia Muscolare di Duchenne e nelle Portatrici. Min. Ped. 1981; 33: 453
   Google Scholar
• Kuby S. A., Keutel H. J., Okabe K., et al. Isolation of human ATP-creatine transphosphorylases (creatine phosphokinases) from tissues of patients with Duchenne muscular dystrophy. J. Biol. Chem. 1977; 252: 8382
   Google Scholar
• Yasmineh W. G., Ibrahim G. A., Abbasnezhad M., et al. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin. Chem. 1978; 24: 1985
   PubMed Web of Science ®Google Scholar
• Munsat T. Creatine phosphokinase alterations in neuromuscular diseases. Isr. J. Med. Sci. 1977; 13: 93
   Google Scholar
• Weinstock I. M., Behrendt J., Wiltshire H. E., et al. Pyruvate kinase: diagnostic value in neuromuscular disease. Clin. Chim. Acta 1977; 80: 415
   Google Scholar
• Zatz M., Shapiro L. J., Campion D. S., et al. Serum pyruvate kinase (PK.) and creatine phosphokinase (CPK) in progressive muscular dystrophies. J. Neurol. Sci. 1978; 36: 349
   PubMed Web of Science ®Google Scholar
• Seay A. R., Ziter F. A., Wu L. H., et al. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers. Neurology 1978; 28: 1047
   Google Scholar
• Kiessling W. R., Beckmann R. Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy. Klin. Wschr. 1981; 59: 347
   PubMedGoogle Scholar
• Demos J. T., Tuil D. G., Katz P. C., et al. Diphenoloxidases in X-linked recessive (Duchenne) muscular dystrophy. Hum. Genet. 1981; 59: 154
   Google Scholar
• Heath R., Jeffery S., Carter N. Radioimmunoassay of human muscle carbonic anhydrase III in dystrophic states. Clin. Chim. Acta 1982; 119: 299
   Google Scholar
• Burri B. J., Chan S. G., Berry A. J., et al. Blood levels of superoxide dismutase and glutathione peroxidase in Duchenne muscular dystrophy. Clin. Chim. Acta 1980; 105: 249
   Web of Science ®Google Scholar
• Hunter M. I. S., Brzeski M. S., de Vane P. J. Superoxide dismutase, glutathione peroxidase and thiobarbituric acid-reactive compounds in erythrocytes in Duchenne musular dystrophy. Clin. Chim. Acta 1981; 115: 93
   PubMed Web of Science ®Google Scholar
• Sen S., Das P. K. Steroid-induced CPK estimation—a new diagnostic test for human muscular dystrophy and its carrier state. Arch. Dis. Child. 1978; 53: 521
   Google Scholar
• Mawatari S., Antoku Y., Kuroiwa Y. Erythrocyte, membrane cation-stimulated ATPase activities in myotonic muscular dystrophy. J. Neurol. Sci. 1982; 53: 23
   Google Scholar
• Ruitenbeek W., Scholte H. R. (Ca++ + Mg++) ATPase of red cells in Duchenne and myotonic dystrophy. Neurology 1980; 30: 1132
   Google Scholar
• Igisu H., Mawatari S., Kuroiwa Y., Miyoshino S. Erythrocyte acetylcholinesterase in Duchenne muscular dystrophy. Clin. Chim. Acta 1980; 105: 241
   Google Scholar
• Igisu H., Antoku Y., Mawatari S., et al. Erythrocyte membrane in myotonic dystrophy. J. Neurol. Sci. 1981; 51: 199
   Google Scholar
• Galbraith D. A., Watts D. C. The effect of ouabain on erythrocyte adenosine triphosphatase activity in relation to cell age in vivo and Duchenne muscular dystrophy. Biochem. Soc. Trans. 1980; 8: 718
   Google Scholar
• Tortolero M., Fischer S., Piau J.-P., et al. Erythrocyte membrane protein kinase and adenylase cyclase in Duchenne muscular dystrophy. Biomedicine 1979; 30: 47
   Google Scholar
• Somer H. Enzyme release from isolated erythrocytes and lymphocytes in Duchenne muscular dystrophy. J. Neurol. Sci. 1980; 48: 445
   Google Scholar
• Davis M. H., Cappel R., Vester J. W., et al. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts. Muscle Nerve 1982; 5: 1
   Google Scholar
• Ionasescu V., Ionasescu R., et al. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy. Ann. Neurol. 1981; 9: 394
   Google Scholar
• Cavanagh N. P. C., Franklin G. I., Hughes B. P., et al. Creatine kinase isoenzymes in cultured human muscle cells. II. A study of carrier females for Duchenne muscular dystrophy by needle and open biopsy. Clin. Chim. Acta 1981; 115: 191
   Google Scholar
• Franklin G. I., Cavanagh N. P. C., Hughes B. P., et al. Creatine kinase isoenzymes in cultured human muscle cells. I. Comparison of Duchenne muscular dystrophy with other myopathic and neurogenic diseases. Clin. Chim. Acta 1981; 115: 179
   Google Scholar
• Thompson C. E. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy. New Engl. J. Med. 1978; 298: 1479
   Google Scholar
• Ionasescu V., Zelleger H., Cancilla P. Fetal serum creatine-phosphokinase not a valid predictor of Duchenne muscular dystrophy. Lancet 1978; 1: 1251
   Google Scholar
• Golbus M. S., Stephens J. D., Mahoney M. J., et al. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. New Engl. J. Med. 1979; 300: 860
   Google Scholar
• Stempel L. E., Lott J. A. Diagnosis of fetal death in utero with amniotic fluid creatine kinase. Am. J. Obstet. Gynecol. 1980; 138: 1173
   Google Scholar
• Kerenyi T., Sarkozi L. Diagnosis of fetal death in utero by elevated anmniotic fluid CPK levels. Obstet. Gynecol. 1974; 44: 215
   Google Scholar
• Carter N. D., Heath R., Jeffery S., et al. Fetal plasma carbonic anhydrase III in Duchenne dystrophy. Lancet 1982; 1: 39
   Google Scholar
• Sibert J. R., Harper P. S., Thompson R. J., et al. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Arch. Dis. Child. 1979; 54: 534
   Google Scholar
• Hutton E. M., Thomson M. W. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Can. Med. Assoc. J. 1976; 115: 749
   Google Scholar
• Perry T. B., Fraser F. C. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Neurology 1973; 23: 1316
   Google Scholar
• Smith I., Thomson W. H. S. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: pyruvate kinase isoenzymes and creatine phosphokinase in serum and blood cells. Clin. Chim. Acta 1977; 78: 439
   PubMed Web of Science ®Google Scholar
• Moss D. W., Whitaker K. B., Parmar C., et al. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the “European” recommended method with NAC-EDTA activation. Clin. Chim. Acta 1981; 116: 209
   Google Scholar
• Tippet P. A., Dennis N. R., Machin D., et al. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods. Clin. Chim. Acta 1982; 121: 345
   Google Scholar
• Percy M. E., Andrews D. F., Thompson W. M. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing. Muscle Nerve 1982; 5: 58
   PubMed Web of Science ®Google Scholar
• Nicholson G. A., Pennington R. J. T., Gardner-Medwin D., et al. Carrier detection in Duchenne muscular dystrophy: assessment of the effect of age on detection-rate with serum creatine-kinase-activity. Lancet 1979; 1: 629
   Google Scholar
• Moser H., Vogt J. Follow up study of serum creatinine kinase in carriers of Duchenne muscular dystrophy. Lancet 1974; 2: 661
   Google Scholar
• Lange K., Zatz M. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Hum. Hered. 1979; 29: 154
   Google Scholar
• Zatz M., Otto P. A. Effect of age on the detection rate in Duchenne muscular dystrophy. Neurol. Sci. 1980; 47: 407
   Google Scholar
• Gale A. N., Murphy E. A. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. J. Chron. Dis. 1979; 32: 639
   Google Scholar
• Smith I., Elton R. A., Thomson W. H. S. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women. Clin. Chim. Acta 1979; 98: 207
   PubMed Web of Science ®Google Scholar
• Nuttall F. Q., Jones B. Creatine kinase and glutamic oxaloacetic transaminase activity in serum: kinetics of change with exercise and effect of physical conditioning. J. Lab. Clin. Med. 1968; 71: 847
   PubMed Web of Science ®Google Scholar
• Berg A., Haralambie G. Changes in serum creatine kinase and hexose phosphate isomerase activity with exercise duration. Eur. J. Appl. Physiol. 1978; 39: 191
   Web of Science ®Google Scholar
• Wolfson S., Rose L. I., Brousser J. E., et al. Serum enzyme levels during exercise in patients with coronary heart disease: effects of training. Am. Heart J. 1972; 84: 478
   Google Scholar
• Ledwich J. R. Changes in serum creatine phosphokinase during submaximal exercise testing. Can. Med. Assoc. J. 1973; 109: 273
   Google Scholar
• McAllister R. G., Weidner L. Effect of treadmill exercise testing on serum enzymes and the resting electrocardiogram. Can. Med. Assoc., J. 1975; 112: 1310
   Google Scholar
• Riley W. J., Pykes F. S., Roberts A. D., et al. The effect of long-distance running on some biochemical variables. Clin. Chim. Acta 1975; 65: 83
   PubMed Web of Science ®Google Scholar
• King S. W., Statland B. E., Savory J. The effect of a short burst of exercise on activity values of enzymes in sera of healthy young men. Clin. Chim. Acta 1976; 72: 211
   PubMed Web of Science ®Google Scholar
• Galteau M. M., Siest G., Poortmans J. Continuous in vivo measurement of creatine kinase variations in man during an exercise. Clin. Chim. Acta 1976; 66: 89
   PubMed Web of Science ®Google Scholar
• Chahine R. A., Kazantzis A., Luchi R. J., et al. Effect of routine treadmill testing on the serum enzymes. Cardiology 1976; 61: 162
   PubMed Web of Science ®Google Scholar
• Goode D. J., Meltzer H. Y. Effects of isometric exercise on serum creatine phosphokinase activity. Arch. Gen. Psychol. 1976; 33: 1207
   Google Scholar
• Kaman R. L., Goheen B., Patton R., et al. The effects of near maximum exercise on serum enzymes: the exercise profile versus the cardiac profile. Clin. Chim. Acta 1977; 81: 145
   PubMed Web of Science ®Google Scholar
• LaPorta M. A., Linde H. W., Bruce D. L., et al. Elevation of creatine phosphokinase in young men after recreational exercise. JAMA 1978; 629: 2685
   Google Scholar
• Olivier L. R., DeWaal A., Retief F. J., et al. Electrocardiographic and biochemical studies on marathon runners. S. Afr. Med. J. 1978; 53: 783
   PubMed Web of Science ®Google Scholar
• Rutledge J., Clayson P. E., Strandjord P. E. Effect of physical conditioning on serum creatine kinase after exercise. JAMA 1978; 240: 2633
   PubMed Web of Science ®Google Scholar
• Houston M., Green H., Thomson J., et al. The response of oxygen consumption, body temperature, blood substrates and serum enzymes to intermittent heavy work performed over 24 hours. Eur. J. Appl. Physiol. 1978; 39: 145
   Google Scholar
• Kielblock A. J., Manjoo M., Booyens J., et al. Creatine phosphokinase and lactate dehydrogenase levels after ultra long-distance running. S. Afr. Med. J. 1979; 55: 1061
   PubMed Web of Science ®Google Scholar
• Haralambie G., Senser L. Metabolic changes in man during long-distance swimming. Eur. J. Appl. Physiol. 1980; 43: 115
   Web of Science ®Google Scholar
• Strauss R. H., Lott J. A., Bartells R., et al. Creatine kinase MB isoenzyme among competitive swimmers. New Engl. J. Med. 1982; 306: 1180
   Google Scholar
• Apple F. S. Presence of creatine kinase MB isoenzyme during marathon training. New Engl. J. Med. 1981; 305: 764
   PubMed Web of Science ®Google Scholar
• Siegel A. J., Silverman L. M., Holman B. L. Elevated creatine kinase MB isoenzyme levels in marathon runners. JAMA 1981; 246: 2049
   PubMed Web of Science ®Google Scholar
• Demos M. A., Gitin E. L., Kagen L. J. Exercise myoglobinemia and acute exertional rhabdomyolysis. Arch. Intern. Med. 1975; 134: 669
   Google Scholar
• Schiff H. B., MacSearraigh E. T. M., Kallmeyer J. C. Myoglobinuria, rhabdomyolysis and marathon running. Q. J. Med. 1978; 47: 463
   PubMedGoogle Scholar
• Innes R. K. R., Stromme J. H. Rise in serum creatine phosphokinase associated with agents used in anaesthesia. Br. J. Anaesth. 1973; 45: 185
   Google Scholar
• Phornphutkul K. S., Anuras S., Koff R. S., et al. Causes of increased plasma creatine kinase activity after surgery. Clin. Chem. 1974; 20: 340
   Google Scholar
• Krafft J., Fink R., Rosalki S. Serum enzymes and isoenzymes after surgery. Ann. Clin. Biochem. 1977; 14: 294
   PubMed Web of Science ®Google Scholar
• Prellwitz W., Neumeier D. Creatine-kinase and CK-MB isoenzyme activity in serum of patients after surgical operations, polytrauma and other damage to skeletal muscle. Clin. Biochem. 1980; 13: 225
   Google Scholar
• Ploetz J., Braun J. Failure of “self-taming” doses of succinylcholine to inhibit increases in postoperative serum creatine kinase activity in children. Anesthesiology 1982; 56: 207
   Google Scholar
• Bendz R., Strom S. Diagnostic significance of serum CK-MB elevations following surgical damage to skeletal muscles. Scand. J. Thorac. Cardiovasc. Surg. 1981; 15: 199
   PubMed Web of Science ®Google Scholar
• Graeber G. M., Snyder R. J., Zajtchuk R., et al. A comparison of serum isoenzyme levels of creatine phosphokinase and lactic dehydrogenase in patients undergoing thoracic operations and patients admitted to a coronary care unit. Ann. Thorac. Surg. 1980; 30: 364
   PubMed Web of Science ®Google Scholar
• Dixon S. H., Limbird L. S., Roe C. R., et al. Recognition of post-operative acute myocardial infarction. Circulation 1973; 47(III)137
   Google Scholar
• Oldham H. N., Roe C. R., Young W. G., et al. Intraoperative detection of myocardial damage during coronary artery surgery by plasma creatine phosphokinase isoenzyme analysis. Surgery 1974; 74: 917
   Google Scholar
• Baur H. R., Steele B. W., Preimesberger K. F., et al. Serum myocardial creatine kinase (CK-MB) after coronary arterial bypass surgery. Am. J. Cardiol. 1979; 44: 679
   PubMedGoogle Scholar
• Pyle R. B., Blomberg D. J., Burke M. D., et al. CPK-MB isoenzyme: use in diagnosis of acute myocardial infarction in early postoperative period. J. Thorac. Cardiovasc. Surg. 1976; 71: 884
   PubMed Web of Science ®Google Scholar
• Warren S. G., Wagner G. S., Bethea C. F., et al. Diagnostic and prognostic significance of electrocardiographic and CPK isoenzyme changes following coronary bypass surgery: correlation with findings at one year. Am. Heart J. 1977; 93: 189
   PubMed Web of Science ®Google Scholar
• Delva E., Maille J. G., Solymoss B. C., et al. Evaluation of myocardial damage during coronary artery grafting with serial determinations of serum CPK-MB isoenzyme. J. Thorac. Cardiovasc. Surg. 1978; 75: 467
   PubMed Web of Science ®Google Scholar
• Roe C. R., Wagner G. S., Young W. G., et al. Relation of creatine kinase isoenzyme MB to postoperative electrocardiographic diagnosis in patients undergoing coronary-artery bypass surgery. Clin. Chem. 1979; 25: 93
   PubMed Web of Science ®Google Scholar
• Sylven J. C. H., Bomfim V., Ivert T., et al. Myocardial and non-myocardial release of myoglobin and creatine-kinase MB following cardiac operations with hypothermic potassium cardioplegia. Cardiovasc. Res. 1982; 16: 151
   PubMedGoogle Scholar
• Klapdor R., Harm K., Kugler G. Forschritte in der Differentialdiagnose des Herzinfarkts. Dtsch. Med. Wschr. 1977; 102: 1309
   Google Scholar
• Anderson D. E., Damsgaard T. The effect on serum enzymes of intramuscular injections of digoxin, bumetanide, pentazocine and isotonic sodium chloride. Acta Med. Scand. 1976; 199: 317
   Google Scholar
• Greenblat D. J., Duhme D. W., Koch-Weser J. Pain and CPK elevation after intramuscular digoxin. New Engl. J. Med. 1973; 288: 689
   Google Scholar
• Klein M. S., Shell W. E., Sobel B. E. Serum creatine phosphokinase (CPK) isoenzymes after intramuscular injections, surgery, and myocardial infarction: experimental and clinical studies. Cardiovasc. Res. 1973; 7: 412
   PubMed Web of Science ®Google Scholar
• Meltzer H. Y., Mrozak S., Boyer M. Effect of intramuscular injections on serum creatine phosphokinase activity. Am. J. Med. Sci. 1970; 259: 42
   PubMed Web of Science ®Google Scholar
• Sidell F. R., Culver D. L., Kaminskis A. Serum creatine phosphokinase activity after intramuscular injection. The effect of dose, concentration and volume. JAMA 1974; 229: 1894
   PubMed Web of Science ®Google Scholar
• Vukovitch R. A. The effect of multiple intramuscular placebo injections on injection-site tolerance and serum creatine phosphokinase activity. Curr. Ther. Res. 1975; 18: 706
   Google Scholar
• Matlof H. J., Buhl J., Wexler L., et al. Serum enzymes and electrocardiograms after coronary arteriography. New Engl. J. Med. 1973; 288: 142
   Google Scholar
• Lindsey D., Navin T. R., Finley P. R. Transient elevations of serum activity of MB isoenzymes of creatine phosphokinase in drivers involved in automobile accidents. Chest 1978; 74: 15
   PubMed Web of Science ®Google Scholar
• Chemnitz G., Schmidt E., Schmidt F. W., et al. Das Creatinkinase Isoenzym MB im Serum bei extrakardialen Erkrankungen. Vern. Dtsch. Ges. Inn. Med. 1978; 84: 1587
   Google Scholar
• Shell W. E., Kligerman M., Rorke M. P., et al. Sensitivity and specificity of MB creatine kinase activity determined with column chromatography. Am. J. Cardiol. 1979; 44: 67
   Google Scholar
• Hackl J. M., Haid B., Puschendorf B., et al. Differentialdiagnose von Skelettmuskel- und Herzmuskeltrauma bei polytraumatischen Verletzungen durch Bestimmung der herzspezifischen Kreatinphos-phokinase (CK-MB). Wien Klin. Wschr. 1978; 90: 595
   Google Scholar
• Biswas C. K., Milligan D. A., Agle S. D., et al. Acute renal failure and myopathy after treatment with amino caproic acid. Br. Med. J. 1980; 281: 115
   Google Scholar
• Lane R. J. M., Mastaglia F. L. Drug-induced myopathies in man. Lancet 1978; 2: 562
   PubMed Web of Science ®Google Scholar
• Schneider J. Clinical importance of clofibrate induced increase of CK catalytic activity in serum. J. Clin. Chem. Clin. Biochem. 1981; 19: 539
   Google Scholar
• Gerard J.-M., Leboutte G. H. C. Crampes musculaires et Elevation des Creatines Kinases induites par le Danazol. Rev. Med. Brux. 1981; 2: 995
   Google Scholar
• Spaulding W. B. Myalgia and elevated creatine phosphokinase with Danazol in hereditary angioedema. Ann. Intern. Med. 1979; 90: 854
   Google Scholar
• Cohen L., Morgan J. DES effects on serum enzyme and isoenzymes in muscular dystrophy. Arch. Neurol. 1976; 33: 480
   PubMedGoogle Scholar
• Cohen L., Morgan J., Bozyk M. E. Effects of the simultaneous administration of DES and prednisolone on serum enzymes in Duchenne's muscular dystrophy. J. Med. 1977; 8: 723
   Google Scholar
• Lui W. Y. Phenothiazine-induced dystonia associated with an increase in serum creatine phosphokinase. Arch. Dis. Child. 1979; 54: 150
   PubMed Web of Science ®Google Scholar
• Teicher A., Rosenthal T., Kissen E., et al. Labetalol-induced toxic myopathy. Br. Med. J. (Clin. Res.) 1981; 282: 1824
   Google Scholar
• Yagiela J. A., Beneit P. W., Buoncristian R. D., et al. Comparison of myotoxic effect of lidocaine with epinephrine in rats and humans. Anaesth. An. 1981; 60: 471
   Google Scholar
• Imatak K., Seki A., Takahashi N., et al. Elevation of serum creatine kinase during pindolol therapy. Tohoku J. Exp. Med. 1981; 133: 363
   Google Scholar
• Weiss M., Hassin D., Eisenstein Z., Bank H. Elevated skeletal muscle enzymes during quinidine therapy. New Engl. J. Med. 1979; 300: 1218
   Google Scholar
• Charak D. S., Dhar C. L. Suxamethonium-induced changes in serum creatine phosphokinase. Br. J. Anaesth. 1981; 53: 955
   Google Scholar
• Lewandowski K. B. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations. Br. J. Anaesth. 1981; 53: 981
   Google Scholar
• Sabiniewicz M., Szajewski J. M. Creatine phosphokinase and barbiturate overdose. Lancet 1979; 152
   Google Scholar
• Wright N., Clarkson A. R., Brown S. S., et al. Effect of poisoning on serum enzyme activities, coagulation and fibrinolysis. Br. Med. J. 1971; 3: 347
   PubMed Web of Science ®Google Scholar
• Lafair J. S., Myerson R. M. Alcoholic myopathy. Arch. Intern. Med. 1968; 122: 417
   PubMedGoogle Scholar
• Nygren A. Serum creatine phosphokinase activity in chronic alcoholism in connection with acute alcohol intoxication. Acta Med. Scand. 1966; 179: 623
   PubMedGoogle Scholar
• DiSilvio T. V. Alcoholic myopathy and changes of serum enzyme activity. Clin. Chem. 1978; 24: 1653
   Google Scholar
• Harm K., Burchard J. M., Bartels E., et al. Differential diagnostic importance of the creatine kinase isoenzyme pattern in delirium tremens. Klin. Wschr. 1979; 57: 943
   Google Scholar
• Henderson L. W., Metz M., Wilkinson J. H. Serum enzyme elevation in glutethimide intoxication. Br. Med. J. 1970; 3: 751
   PubMedGoogle Scholar
• Lithell H., Bobers J., Hellsin K., et al. Increase of lipoprotein lipase activity in human skeletal muscle during clofibrate administration. Eur. J. Clin. Invest. 1978; 8: 67
   Google Scholar
• Abourizk N., Khalil B. A., Bahuth N., et al. Clofibrate-induced muscular syndrome. Report of a case with clinical, electromyographic and pathologic observations. J. Neurol. Sci. 1979; 42: 1
   Google Scholar
• Cans W. R., Hoffman J., Huebschmann K., et al. Myopathy induced by clofibrate treatment in normolipemic patients. Acta Paediatr. Acad. Sci. Hung. 1979; 20: 109
   Google Scholar
• Schneider J., Muehlfellner G., Kaffarnik H. Creatine kinase in hyperlipoproteinemic patients treated with clofibrate. Artery 1980; 8: 164
   Google Scholar
• Sheffer A. C., Fearson D. T., Austen K. F. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J. Allergy Clin. Immunol. 1981; 68: 181
   PubMed Web of Science ®Google Scholar
• Fraser A. D. Chemotherapy as a cause of low serum creatine kinase activity. Clin. Chem. 1980; 26: 1629
   PubMed Web of Science ®Google Scholar
• Siegel A. J., Dawson D. M. Peripheral source of MB band of CK in alcoholic rhabdomylosis. Non-specificity of MB isoenzyme for myocardial injury in undiluted serum samples. JAMA 1980; 244: 580
   PubMedGoogle Scholar
• Spector R., Choudhury A., Cancilla P., et al. Alcoholic myopathy. Diagnosis by alcohol challenge. JAMA 1979; 242: 1648
   Google Scholar
• Langohr H. D., Schumm F., Luithle H. J., et al. Vergleichende biochemische und elektrophysiol-ogische Untersuchungen in der Skeletmuskulatur bei Alkoholismus. Arch. Psychiatr. Nervenkr. 1977; 223: 249
   Google Scholar
• Marian C., Meola G., Meroni P. L., et al. Pentazocine-induced neuromuscular syndromes: clinical, immunological and histopathological studies in two cases. Acta Neuropathol. Suppl. (Bed.) 1981; 7: 246
   Google Scholar
• Dolich B. H., Aiache A. E. Drug-induced coma: a cause of crush syndrome and ischemic contracture. J. Trauma 1973; 13: 223
   PubMed Web of Science ®Google Scholar
• Galen R. S. In the aftermath of drug-induced coma, suspect crush syndrome. Diag. Med. Nov.-Dec. 9, 1979
   Google Scholar
• Sueblinvong V., Wilson J. F. Myocardial damage due to imipramine intoxication. Pediatr. Pharmacol. Ther. 1969; 74: 475
   Google Scholar
• Demeyere R. Malignant hyperthemia. Acta Anaesth. Belg. 1978; 29: 101
   Google Scholar
• Britt B. A. Etiology and pathophysiology of malignant hyperthermia. Fed. Proc. 1979; 38: 44
   PubMedGoogle Scholar
• Gronert G. A. Malignant hyperthermia. Anesthesiology 1980; 53: 395
   PubMed Web of Science ®Google Scholar
• Britt B. A., Endrenyi L., Peters P. L. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Can. Anaesth. Soc. J. 1976; 23: 263
   PubMedGoogle Scholar
• Pandit S. K., Kothary S. P., Cohen P. J. Orally administered dantrolene for prophylaxis of malignant hyperthermia. Anesthesiology 1979; 50: 156
   Google Scholar
• Bronstein S. L., Ryan D. E., Solomons C. C., et al. Dantrolene sodium in the management of patients at risk for malignant hyperthermia. J. Oral Surg. 1979; 37: 719
   Google Scholar
• Dodd M. J., Phattiyakl P., Silpasuvan S. Suspected malignant hyperthermia in a strabismus patient. A case report. Arch. Ophthalmol. 1981; 99: 1247
   Google Scholar
• Caccia M. R., Cerri C., Gravame V., et al. Myopathy with paroxysmal myoglobinuria and focal muscle necrosis following enfluorane anesthesia. J. Neurol. Sci. 1978; 39: 61
   Google Scholar
• Fitzgibbon D. C. Malignant hyperthermia following preoperative oral administration of dantrolene. Anesthesiology 1981; 54: 73
   Google Scholar
• Henderson W. V., Wooten G. F. Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockage?. Neurology 1981; 31: 132
   PubMed Web of Science ®Google Scholar
• Torn M., Matsuda O., Makiguchi K., et al. Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J. Nerv. Ment. Dis. 1981; 169: 324
   Google Scholar
• Malas K. L., Van Kammen D. P. Marked elevated CK levels after neuroleptic withdrawal. Am. J. Psychiatry 1982; 139: 231
   Google Scholar
• Pedersen L. M., Nygaard E., Nielsen D. S., et al. Solvent-induced occupational myopathy. J. Occup. Med. 1980; 22: 603
   PubMedGoogle Scholar
• Morse D. L., Kominsky J. R., Wisseman C. L., et al. Occupational exposure to hexachlorocylo-pentadiene. How safe is sewage?. JAMA 1979; 241: 2177
   PubMed Web of Science ®Google Scholar
• Hoffman T. A., Ruiz C. J., Counts G. W., et al. Waterbome typhoid fever in Dade county, Florida. Am. J. Med. 1975; 59: 481
   PubMed Web of Science ®Google Scholar
• David C. B., Tolaymat A. Typhoid fever: unusual presentation. J. Pediatr. 1978; 95: 533
   Google Scholar
• Lott J. A., Speicher C. E., Ayers L. W. Typhoid fever toxemia with associated destruction of skeletal muscle. Clin. Chem. 1980; 26: 1361
   Google Scholar
• Kiyasu J. Detection of septicemia by the shot-gun method for assaying creatine kinase isoenzyme MB in serum. Clin. Chem. 1978; 24: 2064
   Google Scholar
• Sexton D. J., Banks P. M., Weig S., et al. Late appearance of skin rash and abnormal serum enzymes in Rocky Mountain spotted fever: a case report. J. Pediatr. 1975; 87: 580
   PubMed Web of Science ®Google Scholar
• Johnson W. D., Jr., Silva C., Rocha H. Serum creatine phosphokinase in leptospirosis. JAMA 1975; 233: 981
   PubMed Web of Science ®Google Scholar
• Farkas P. S., Knapp A. B., Lieberman H., et al. Markedly elevated creatinine phosphokinase, cotton wool spots, and pericarditis in a patient with leptospirosis. Gastroenterology 1981; 80: 587
   Google Scholar
• Friman G. Serum creatine phosphokinase in epidemic influenza. Scand. J. Infect. Dis. 1976; 8: 13
   PubMedGoogle Scholar
• Chandar K., Mair H. J., Mair N. S. Case of toxoplasma polymyositis. Br. Med. J. 1968; 1: 158
   Google Scholar
• Dobrin R. S. Reye's syndrome—1980. Resid Staff Physics March, 1980; 79
   Google Scholar
• Atkins J. N., Haponik E. F. Reye's syndrome in the adult patient. Am. J. Med. 1979; 67: 672
   PubMed Web of Science ®Google Scholar
• Rock R. C., Dreskin R., Kickler T., et al. Creatine kinase isoenzymes in serum of patients with Reye's syndrome. Clin. Chim. Acta 1975; 62: 159
   PubMed Web of Science ®Google Scholar
• Roe C. R., Schonberger L., Gehlbach S. H., et al. Enzymatic alterations in Reye's syndrome: prognostic implications. Pediatrics 1975; 55: 119
   PubMed Web of Science ®Google Scholar
• Forman D. T., Kieffer H., Grayson S. H. Serum creatine kinase inhibition in Reye's syndrome. Clin. Chem. 1977; 23: 1364
   PubMed Web of Science ®Google Scholar
• Edwards R. H. T., Isenberg D. A., Wiles C. M., et al. The investigation of inflammatory myopathy. J. R. Coll. Phys. 1981; 15: 19
   Google Scholar
• Durston J. H. J. Disorders of skeletal muscle. Br. J. Hosp. Med. 1974; 11: 590
   Google Scholar
• Robbins S. L. Pathologic Basis of Disease. W. B. Saunders, Philadelphia 1974; 239
   Google Scholar
• Pearce J. M. S., Pennington R. J., Walton J. N. Serum enzyme studies in muscle disease. II. Serum creatine kinase activity in muscular dystrophy and in other myopathic and neuropathic disorders. J. Neurol. Neurosurg. Psychiatry 1964; 27: 96
   PubMed Web of Science ®Google Scholar
• Richterich R., Rosin S., Aebi U., et al. Progressive muscular dystrophy, V. The identification of the carrier state in the Duchenne type by serum creatine kinase determination. Am. J. Hum. Genet. 1963; 15: 133
   PubMed Web of Science ®Google Scholar
• Vladutiu A. O., Venuto R. C. Creatine kinase MB and lactate dehydrogenase-5 isoenzymes in rhabdomyolysis. Clin. Chem. 1977; 23: 1366
   Google Scholar
• Brownlow K., Elevitch F. R. Serum creatine phosphokinase isoenzyme (CPK 2) in myositis. JAMA 1974; 230: 1141
   PubMed Web of Science ®Google Scholar
• Tsung S. H., Huang T. Y., Han D., et al. Total creatine kinase and isoenzyme MB activity in serum and skeletal muscle of a patient with dermatomyositis. Clin. Chem. 1980; 26: 1912
   PubMed Web of Science ®Google Scholar
• Tsung S. H., Huang T. Y., Lin J. I. CK-MB isoenzyme in patients with polymyositis. Am. J. Med. Sci. 1982; 283: 174
   Google Scholar
• Larca L. J., Coppola J. T., Honig S. Creatine kinase MB isoenzyme in dermatomyositis: a noncardiac source. Ann. Intern. Med. 1981; 94: 341
   PubMedGoogle Scholar
• Morton B. D., Statland B. E. Serum enzyme alterations in polymyositis: possible pitfalls in diagnosis. Am. J. Clin. Pathol. 1980; 73: 556
   PubMed Web of Science ®Google Scholar
• Cros D., Pearson C., Verity M. A. Polymyositis-dermatomyositis. Am. J. Pathol. 1980; 101: 159
   PubMed Web of Science ®Google Scholar
• Griffiths P. D. Serum enzymes in diseases of the thyroid gland. J. Clin. Pathol. 1965; 18: 660
   PubMed Web of Science ®Google Scholar
• Doran G. R., Wilkinson J. H. The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxoedema. Clin. Chim. Acta 1975; 62: 203
   PubMedGoogle Scholar
• Gaeda J. T. Serum enzyme alterations in hypothyroidism before and after treatment. J. Am. Geriatr. Soc. 1977; 25: 199
   Google Scholar
• Feix C., Skachova J., Kunova V. Creatine phosphokinase in thyroid disease. Rev. Czech. Med. 1977; 23: 133
   Google Scholar
• Goldman J., Matz R., Mortimer R., et al. High elevations of creatine phosphokinase in hypothyroidism. An isoenzyme analysis. JAMA 1977; 238: 325
   PubMed Web of Science ®Google Scholar
• Jenkins D. J. An investigation into creatine kinase and other plasma enzymes in thyroid disorders. Clin. Chim. Acta 1978; 85: 197
   Google Scholar
• Emser W., Schimrigk K. Myxedema myopathy: a case report. Eur. J. Neurol. 1977; 16: 286
   Google Scholar
• Goto I. Serum creatine phosphokinase isoenzymes in hypothyroidism, convulsion, myocardial infarction and other diseases. Clin. Chim. Acta 1974; 52: 27
   PubMed Web of Science ®Google Scholar
• Fleisher G. A., McConahey W. M., Pankow M. Serum creatine kinase, lactic dehydrogenase, and glutamic-oxalacetic transaminase in thyroid disease and pregnancy. Mayo Clin. Proc. 1965; 40: 300
   PubMed Web of Science ®Google Scholar
• Smith D. P. The relationship between serum creatine kinase and thyroid hormones: in vivo and in vitro studies. Clin. Chim. Acta 1976; 68: 333
   PubMed Web of Science ®Google Scholar
• Crawhall J. C., Tolis G., Roy D. Elevation of serum creatine kinase in severe hypokalemic hyperaldosteronism. Clin. Biochem. 1976; 9: 237
   PubMedGoogle Scholar
• Hoag G. N., Franks G. R., DeCoteau W. E. Creatine kinase isoenzymes in serum of patients with cancer of various organs. Clin. Chem. 1978; 24: 1654
   PubMed Web of Science ®Google Scholar
• Bruns D. E., Morgan W. S., Davis J. E., et al. Low apparent creatine kinase activity and prolonged lag phases in serum of patients with metastatic disease: elimination by treatment of sera with sulfhydryl agents. Clin. Chem. 1976; 22: 1889
   PubMed Web of Science ®Google Scholar
• Yu H., Takagi Y., Senju O., et al. Creatine kinase isoenzyme of high relative molecular mass in serum of a cancer patient. Clin. Chem. 1978; 24: 2054
   Google Scholar
• Calvin A. Raised serum creatine phosphokinase activity in ankylosing spondylitis. Ann. Rheum. Dis. 1975; 34: 244
   Google Scholar
• Halvorson H. C., Bias H. I., Kaldahl P. E., et al. Elevated creatine phosphokinase in patients with urethral calculi. Cause for unwarranted concern of coronary occlusion. Urology 1974; 4: 254
   Google Scholar
• Konttinen A., Somer H., Auvinen S. Serum enzymes and isoenzymes, extrapulmonary sources in acute pulmonary embolism. Arch. Int. Med. 1974; 133: 243
   PubMedGoogle Scholar
• Lemberg A., Werber D. H., Gilardoni A., et al. Presence of serum creatine kinase isoenzymes in liver failure with cerebral involvement. Clin. Chim. Acta 1977; 80: 385
   PubMed Web of Science ®Google Scholar
• Barlogie B., Corry P. M., Yip E., et al. Total body hyperthermia with and without chemotherapy for advanced human neoplasms. Cancer Res. 1979; 39: 1481
   PubMed Web of Science ®Google Scholar
• Carlson C. J., Emilson B., Rapaport E. Creatine phosphokinase MB isoenzymes in hypothermia: case reports and experimental studies. Am. Heart J. 1973; 95: 352
   Google Scholar
• Heinz J. A., O'Donnell N. J., Lott J. A. Apparent mitochondrial creatine kinase in the serum of a patient with metastatic cancer to the liver. Clin. Chem. 1980; 26: 1908
   PubMed Web of Science ®Google Scholar
• Kwong T. C., Arvan D. A. How many creatine kinase isoenzymes are there and what is their clinical significance?. Clin. Chim. Acta 1981; 115: 3
   Google Scholar
• Tsung S. W. Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin. Chem. 1976; 22: 173
   PubMed Web of Science ®Google Scholar
• Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended methods for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand. J. Clin. Lab. Invest. 1979; 39: 1
   Google Scholar
• Bodensteiner J. B., Zellweger H. Creatine phosphokinase in normal neonates and young infants. J. Lab. Clin. Med. 1971; 11: 853
   Google Scholar
• Rudolph N., Gross R. T. Creatine phosphokinase activity in serum of newborn infants as an indicator of fetal trauma during birth. Pediatrics 1966; 38: 1039
   PubMedGoogle Scholar
• Menzel K., Braun W. F. Verteilungsmuster der Serum-LDH und -CPK bei gesunden Neugeborenen. Kinderaerztl. Prax 1974; 42: 128
   Google Scholar
• Dubowitz V. Screening for Duchenne muscular dystrophy. Arch. Dis. Child. 1976; 51: 249
   Google Scholar
• Gilboa N., Swanson J. R. Serum creatine phosphokinase in normal newborns. Arch. Dis. Child. 1976; 51: 283
   PubMedGoogle Scholar
• Jouppila R., Jouppila P., Koivisto M., et al. Maternal, fetal, and neonatal blood creatine phosphokinase activities and creatine phosphokinase isoenzymes after labor with and without epidural analgesia and after Caesarean section. Acta Anaesth. Scand. 1978; 22: 491
   PubMedGoogle Scholar
• Drummond L. M. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch. Dis. Child. 1979; 54: 362
   Google Scholar
• Cao A., Trabalza N., DeVirgilis S., et al. Serum creatine kinase activity and serum CK isoenzymes in newborn infants. Biol. Neonate 1971; 17: 126
   Google Scholar
• Hess J. W., MacDonald R. P., Natho G. J. W., et al. Serum creatine phosphokinase: Evaluation of a commercial spectrophotometric method. Clin. Chem. 1967; 13: 994
   PubMed Web of Science ®Google Scholar
• Wiesman M., Columbo J. P., Adam A., et al. Determination of cysteine activated creatine kinase in serum. Enzymol. Biol. Clin. 1966; 7: 266
   Google Scholar
• Verri B., Macagno F., Corazza G. Creatine phosphokinase (CPK) in children of different ages. Minerva Pediat. 1966; 18: 2256
   Google Scholar
• Cherian A. G., Hill J. G. Age dependence of serum enzymatic activities (alkaline phosphatase, aspartate aminotransferase and creatine kinase) in healthy children and adolescents. Am. J. Clin. Pathol. 1978; 70: 783
   PubMed Web of Science ®Google Scholar
• Worthy E., Whitehead P., Goldberg D. M. Advantages and limitations of a simplified colorimetric assay for ATP: creatine phosphotransferase activity of human serum. Enzymol. Biol. Clin. 1970; 11: 193
   PubMedGoogle Scholar
• Griffiths P. D. Serum levels of ATP: reatine phosphotransferase (creatine kinase): the normal range and effect of muscular activity. Clin. Chim. Acta 1966; 13: 413
   PubMedGoogle Scholar
• Garcia W. Elevated creatine phosphokinase levels associated with large muscle mass. JAMA 1974; 228: 1395
   PubMed Web of Science ®Google Scholar
• Thomson W. H. S. Determination and statistical analysis of the normal ranges for five serum enzymes. Clin. Chim. Acta 1968; 21: 469
   PubMed Web of Science ®Google Scholar
• Szasz G., Busch E. W., Farohs H. B. Serum Kreatinkinase. Dtsch. Med. Wschr. 1970; 95: 829
   PubMedGoogle Scholar
• Feraudi M., Harm K., Schmidt H. Statische Untersuchung der Frage der Normalwerte und der physiologischen Variabilitaet der Serum-Kreatin-Phosphokinase. Enzymol. Biol. Clin. 1968; 9: 338
   Google Scholar
• Meltzer H. Y. Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity, and age. Clin. Chim. Acta 1971; 33: 165
   PubMed Web of Science ®Google Scholar
• Lott J. A., Wenger W. C., Massion C. G., et al. Interlaboratory survey of enzyme analyses. IV. Am. J. Clin. Pathol. 1982; 78: 626
   Google Scholar
• Perry T. B., Fraser F. C. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Neurology 1973; 23: 1316
   Google Scholar
• Bundey S., Crawley J. M., Edwards J. H., et al. Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women. J. Med. Genet. 1979; 16: 117
   PubMed Web of Science ®Google Scholar
• Smith I., Elton R. A., Thomson W. H. S. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women. Clin. Chim. Acta 1979; 98: 207
   PubMed Web of Science ®Google Scholar
• Chemnitz G., Nevermann K., Schmidt E., et al. Creative kinase and creatine kinase isoenzymes during pregnancy and labor and in the cord blood. Clin. Biochem. 1980; 13: 277
   PubMedGoogle Scholar
• McNeely M. D. D., Berris B., Papsin F. R., et al. Creatine kinase and its isoenzymes in the serum of women during pregnancy and the peripartum period. Clin. Chim Acta 1977; 23: 1878
   Google Scholar
• Amador E., Ansar A. Analytical aspects of clinical enzymology. aClinical Chemistry, D. T. Forman, R. W. Mattoon. American Chemical Society, Washington, DC 1976; 36
   Google Scholar
• Lott J. A., Turner K. Lactate dehydrogenase in serum. Selected Methods for the Small Clinical Chemistry Laboratory, W. R. Faulkner, S. Meites. W. B. Saunders, Philadelphia 1982; 271
   Google Scholar
• Wroblewski F., Gregory K. F. Lactic dehydrogenase isoenzymes and their distribution in normal tissue and plasma and in disease states. Ann. N. Y. Acad. Sci. 1961; 94: 912
   PubMed Web of Science ®Google Scholar
• Meites S. Pediatric Clinical Chemistry. American Association for Clinical Chemistry. 1982; 300
   Google Scholar
• Expert Panel on Enzymes. Clin. Chim. Acta 1980; 105: 147F
   Google Scholar
• Anon. Provisional recommendation on I. F. C. C. methods for the measurement of catalytic concentrations of enzymes. Clin. Chim. Acta 1976; 70: F19
   Google Scholar
• Wroblewski F. Clinical significants of alterations in transaminase activities of serum and other body fluids. Adv. Clin. Chem. 1958; 1: 313
   PubMed Web of Science ®Google Scholar
• Caraway W. T. Chemical and diagnostic specificity of laboratory tests. Effect of hemolysis, lipemia, anticoagulants, medications, contaminants, and other variables. Am. J. Clin. Pathol. 1962; 37: 445
   PubMed Web of Science ®Google Scholar
• Meites S. Pediatric Clinical Chemistry. American Association for Clinical Chemistry. 1982; 59, 117
   Google Scholar
• Meites S. Pediatric Clinical Chemistry. American Association for Clinical Chemistry. 1982; 63
   Google Scholar
• Cederblad C., Bylund A. C., Holm J., et al. Carnitine concentration in relationship to enzyme activities and substrate utilization. Scand. J. Clin. Invest. 1976; 36: 547
   PubMed Web of Science ®Google Scholar
• Haralambie G. Fumarase activity in skeletal muscle of man. Biomedicine 1977; 27: 255
   PubMedGoogle Scholar
• Adolph L., Lorenz R. Enzyme Diagnosis in Diseases of the Heart, Liver, and Pancreas. S. Karger AG, Switzerland 1982; 14
   Google Scholar
• Lott J. A., Heinz J. W. Creatine kinase in serum. Selected Methods for the Small Clinical Chemistry Laboratory, W. R. Faulkner, S. Meites. W. B. Saunders, Philadelphia 1982; 185
   Google Scholar
• Lott J. A. Creatine kinase isoenzymes in serum. Selected Methods for the Small Clinical Chemistry Laboratory, W. R. Faulkner, S. Meites. W. B. Saunders, Philadelphia 1982; 191
   Google Scholar